Skip to content
Alivexis, Inc.

Alivexis, Inc.

Unveiling the Future of Medicine

Menu

  • Home
  • Science
  • Pipeline
  • About Us
  • News
  • Public Notice
  • Contact Us
  • 日本語

News

News

Modulus Discovery Announces the Initiation of a Research Collaboration with Prof. Tsutomu Suzuki, University of Tokyo- 31 October, 2018

Modulus Discovery Announces Signing of a Multi-Target Research Collaboration with Professor Osamu Nureki, University of Tokyo- 04 September, 2018

Modulus Raises 800M Japanese Yen for Its Series A Funding Round- 09 August, 2018

Modulus Announces the Appointment of Former Senior Pharma Executive, Professor Wataru Uchida, as Scientific Advisor- 31 July, 2018

Modulus Discovery Announces the Appointment of Hiroko Nishimoto As Advisor- 01 June, 2018

Modulus Discovery Announces the Appointment of Taisuke Takahashi, Ph.D. as Vice President and Head Of Chemistry- 01 April, 2018

Modulus Discovery Announces the Appointment of Yoh Terada, Ph.D. as Chief Scientific Officer- 02 January, 2018

Modulus Discovery Establishes Wholly Owned U.S. Subsidiary and R&D Office in Cambridge, MA- 15 December, 2017

Modulus Discovery Announces the Appointment of Koji Tsuda As Scientific Advisor- 11 October, 2017

Modulus Discovery Announces the Appointment of Yutaka Akiyama as Scientific Advisor- 01 October, 2017

Previous
Next

Press & Media Contact

Latest Release

  • Alivexis Announces Receipt of Intention to Exercise Option Right from Astellas Pharma Inc. for Collaboration on Novel Drug Target
  • Notice of Selection for the Ministry of Economy, Trade and Industry’s Domestic Generative AI Development Strengthening Project “GENIAC”
  • Alivexis to Present at the 2025 BIO International Convention
  • Alivexis To Present at GTC 2025 Japan AI Day
  • Alivexis Raises $0.7M USD Series D in Second Close
  • LinkedIn

 (c) Copyright 2025, Alivexis, Inc.
Privacy Policy Terms of Use

Copyright © 2026 Alivexis, Inc.. All rights reserved. Theme Spacious by ThemeGrill. Powered by: WordPress.